Nambulli S, Escriou N, Rennick LJ, Demers MJ, et al. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. J Virol 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
PMID: 38563762